223 — Elife Holdings Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Elife Holdings, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -95.9 | -28.9 | -44.9 | -25.2 | -23.8 |
Depreciation | |||||
Non-Cash Items | 35.5 | 9.55 | 25.3 | 2.3 | 27 |
Discontinued Operations | |||||
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 27.8 | 2.91 | 1.5 | 3.68 | -34.2 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -23 | -10.9 | -14.7 | -16.4 | -28.9 |
Capital Expenditures | -0.063 | -0.106 | 0 | -0.042 | -0.002 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.968 | 0.371 | 5.85 | 0.001 | 0.004 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0.905 | 0.265 | 5.85 | -0.041 | 0.002 |
Financing Cash Flow Items | 13.9 | 0.212 | -0.014 | 2.19 | -4.84 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 19.8 | 8.21 | 5.07 | 8.02 | 54.3 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -3.18 | -1.61 | -3.78 | -8.52 | 24.9 |